Full text is available at the source.
Abstract
Prime editing has the potential to enable precise genetic modifications without inducing double-strand breaks.
- It allows for point mutations, insertions, and deletions in genetic material.
- Structural modifications have improved its precision, efficacy, and safety.
- Prime editing is currently being tested in clinical trials for chronic granulomatous disease.
- Numerous preclinical studies are in progress to explore its applications further.
- Challenges remain regarding the efficient and safe delivery of this technology to target tissues.
Simplified